Irwin Naturals Bringing Its Household Name Brand to the Psychedelic Mental Health SpaceTryp Therapeutics Announces Inclusion in AdvisorShares Psychedelics ETFMindMed and Liechti Lab Provide Results from their Psilocybin R&D CollaborationPsyched Wellness Announces Inclusion in AdvisorShares Psychedelics Exchange Traded Fund (ETF)Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating DisordersPsyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its NoveHow Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic AnalogsSilo Pharma Advances Psychedelic Patent PortfolioTryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of FloridaMajor Psychedelic Clinical Trial Data Is Right Around The CornerPsychedelic Drug Development Companies Are Leveraging Bolt On MedTech Acquisitions To Create A More Robust Patient Care 7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan
Back

Havn Life Sciences and Nesters Market, a Leading Canadian Retailer of Natural Health and Wellness Products, Announce an Authorized Products Listing

Dec 22, 2020 • 8:27 AM EST
4 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP(the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds, the development of a full range of natural healthcare products, and innovative mental health treatment, is pleased to announce a product listing agreement for a range of Havn Life’s natural health products, which will be sold in select Nesters Markets in British Columbia.

The range of products will hit shelves across British Columbia in Q1/Q2 of 2021.

“This is a major milestone for Havn Retail, enabling us to reach our goal of launching our initial product line in the market for early 2021. Nesters Market is recognized across British Columbia as a provider of high quality items and has been an early adopter of many new product lines, Havn Life’s formulations are bioavailable and naturally-derived and are created with human optimization in mind. The products have been thoughtfully formulated with adaptogens and antioxidants to aid in overall brain health.” said Tim Moore, CEO of Havn Life.

Seven formulations are to be included in Havn Life’s initial product launch:

  • Mind Mushroom: A blend of four mushrooms, mind is designed to help balance the immune system, fight cell damage and increase energy.
  • Bacopa Brain: Bacopa is a powerful plant extract that is clinically proven to support cognitive function and the nervous system.
  • Rhodiola Relief: Formulated to support mental focus and mental stamina.
  • Cordyceps Perform: Cordyceps mushrooms help support a healthy immune system.
  • Chaga Immunity: Chaga mushrooms help stimulate the immune system and control inflammation in the body.
  • Reishi Recharge: this multi-purpose mushroom has also been used in Traditional Chinese Medicines to strengthen the heart to reduce fatigue, insomnia and appetite as well as coughs and wheezing.
  • Lion’s Mane Memory: Lion’s mane helps maintain and balance the immune system.

“We are excited to get our first range of products to market next year and will continue to develop formulations that can support brain health,” says Gary Leong, Chief Science Officer. “We have the opportunity to leverage our scientific expertise to deliver effective products. These products are supported with the latest scientific evidence and the most stringent quality and manufacturing standards,” Gary Leong.

“As we introduce these products to market, Havn Life will utilize a multi-pronged distribution strategy including online, retail, subscription and other channels to reach a broad customer base and deliver a quality customer experience,” said Tim Moore.

On Behalf of The Board of Directors

Tim Moore
Chief Executive Officer

About Nesters Market

Nesters Market is an award-winning grocery store company with locations across British Columbia and Alberta. The company’s philosophy is to provide clean, modern, full-service food stores that sell high quality goods at a fair price, are the focal point of their community, with a culture that encourages people to have fun, be involved with and to take pride in the customers, products, and services we deliver.

About Havn Life Sciences Inc.

Havn Life Sciences is a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, and innovative mental health treatment to support brain health and enhance the capabilities of the mind. Learn more at: havnlife.com and follow us on FacebookTwitter and Instagram.

Contact:

Investor Relations: ir@havnlife.com 604 687 7130
Media: brittany@exvera.com 778 238 6096

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

SOURCE: Havn Life Sciences Inc.

View source version on accesswire.com:
https://www.accesswire.com/621856/Havn-Life-Sciences-and-Nesters-Market-a-Leading-Canadian-Retailer-of-Natural-Health-and-Wellness-Products-Announce-an-Authorized-Products-Listing

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link